These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34977183)

  • 21. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients.
    Florian A; Ludwig A; Engelen M; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
    J Cardiovasc Magn Reson; 2014 Sep; 16(1):81. PubMed ID: 25315351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
    Riffel JH; Keller MG; Rost F; Arenja N; Andre F; Aus dem Siepen F; Fritz T; Ehlermann P; Taeger T; Frankenstein L; Meder B; Katus HA; Buss SJ
    J Cardiovasc Magn Reson; 2016 Jun; 18(1):36. PubMed ID: 27268238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study.
    Amzulescu MS; Rousseau MF; Ahn SA; Boileau L; de Meester de Ravenstein C; Vancraeynest D; Pasquet A; Vanoverschelde JL; Pouleur AC; Gerber BL
    JACC Cardiovasc Imaging; 2015 Aug; 8(8):934-46. PubMed ID: 26189121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy.
    Doesch C; Dierks DM; Haghi D; Schimpf R; Kuschyk J; Suselbeck T; Schoenberg SO; Borggrefe M; Papavassiliu T
    Int J Cardiol; 2014 Dec; 177(2):429-35. PubMed ID: 25304065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy.
    Nabeta T; Inomata T; Iida Y; Ikeda Y; Iwamoto M; Ishii S; Sato T; Watanabe I; Naruke T; Shinagawa H; Koitabashi T; Takeuchi I; Nishii M; Inoue Y; Izumi T
    Heart Vessels; 2014 Nov; 29(6):784-92. PubMed ID: 24092362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain.
    Ochs A; Riffel J; Ochs MM; Arenja N; Fritz T; Galuschky C; Schuster A; Bruder O; Mahrholdt H; Giannitsis E; Frey N; Katus HA; Buss SJ; André F
    J Cardiovasc Magn Reson; 2021 Dec; 23(1):136. PubMed ID: 34852822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
    Neilan TG; Coelho-Filho OR; Danik SB; Shah RV; Dodson JA; Verdini DJ; Tokuda M; Daly CA; Tedrow UB; Stevenson WG; Jerosch-Herold M; Ghoshhajra BB; Kwong RY
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):944-54. PubMed ID: 23932642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group.
    Alba AC; Gaztañaga J; Foroutan F; Thavendiranathan P; Merlo M; Alonso-Rodriguez D; Vallejo-García V; Vidal-Perez R; Corros-Vicente C; Barreiro-Pérez M; Pazos-López P; Perez-David E; Dykstra S; Flewitt J; Pérez-Rivera JÁ; Vazquez-Caamaño M; Katz SD; Sinagra G; Køber L; Poole J; Ross H; Farkouh ME; White JA
    Circ Cardiovasc Imaging; 2020 Apr; 13(4):e010105. PubMed ID: 32312112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.
    Di Marco A; Anguera I; Schmitt M; Klem I; Neilan TG; White JA; Sramko M; Masci PG; Barison A; Mckenna P; Mordi I; Haugaa KH; Leyva F; Rodriguez Capitán J; Satoh H; Nabeta T; Dallaglio PD; Campbell NG; Sabaté X; Cequier Á
    JACC Heart Fail; 2017 Jan; 5(1):28-38. PubMed ID: 28017348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
    Kwon DH; Halley CM; Carrigan TP; Zysek V; Popovic ZB; Setser R; Schoenhagen P; Starling RC; Flamm SD; Desai MY
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):34-44. PubMed ID: 19356530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myocardial Magnetic Resonance Texture Characteristics of Healthy Volunteers].
    Wu T; Sun HQ; Liu XM; Chen YC; Dong Y; He S; Wan K; Cheng W; Gao FB; Sun JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):494-499. PubMed ID: 31642225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
    Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
    Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
    J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.